{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:42:01Z","timestamp":1785807721019,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Huimin Project of Zhengzhou","award":["2021KJHM0003"],"award-info":[{"award-number":["2021KJHM0003"]}]},{"name":"Youth Project of Natural Science Foundation of Henan Province","award":["202300410387"],"award-info":[{"award-number":["202300410387"]}]},{"name":"Medical Science and Technology Cooperation Project of Henan Province","award":["2018020036"],"award-info":[{"award-number":["2018020036"]}]},{"name":"Key Scientific Research Projects in Colleges and Universities of Henan Province","award":["22A320075"],"award-info":[{"award-number":["22A320075"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The next generation sequencing (NGS) based non-invasive prenatal test (NIPT) has outplayed the traditional serum biochemical tests (SBT) in screen of fetal aneuploidies with a high sensitivity and specificity. However, it has not been widely used as a primary screen tool due to its high cost and the cheaper SBT is still the choice for primary screen even with well-known shortages in sensitivity and specificity. Here, we report a multiplex droplet digital PCR NIPT (dPCR-NIPT) assay that can detect trisomies 21, 18 and 13 (T21, T18 and T13) in a single tube reaction with a better sensitivity and specificity than the SBT and a much cheaper price than the NGS-NIPT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, the dPCR-NIPT assay\u2019s non-clinical characteristics were evaluated to verify the cell free fetal DNA (cffDNA) fraction enrichment efficiencies, the target cell free DNA (cfDNA) concentration enrichment, the analytical sensitivity, and the sample quality control on the minimum concentration of cfDNA required for the assay. We validated the clinical performance for this assay by blindly testing 283 clinical maternal plasma samples, including 36 trisomic positive samples, from high risk pregnancies to access its sensitivity and specificity. The cost effectiveness of using the dPCR-NIPT assay as the primary screen tool was also analyzed and compared to that of the existing contingent strategy (CS) using the SBT as the primary screen tool and the strategy of NGS-NIPT as the first-tier screen tool in a simulating situation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>For the non-clinical characteristics, the sample processing reagents could enrich the cffDNA fraction by around 2 folds, and the analytical sensitivity showed that the assay was able to detect trisomies at a cffDNA fraction as low as 5% and the extracted cfDNA concentration as low as 0.2\u00a0ng\/\u03bcL. By testing the 283 clinical samples, the dPCR-NIPT assay demonstrated a detection sensitivity of 100% and a specificity of 95.12%. Compared to the existing CS and the NGS-NIPT as the first-tier screen strategy, dPCR-NIPT assay used as a primary screen tool followed by the NGS-NIPT rescreen is the most economical approach to screen pregnant women for fetal aneuploidies without sacrificing the positive detection rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is the first report on a dPCR-NIPT assay, consisting of all the necessary reagents from sample processing to multiplex dPCR amplification, can detect T21, T18 and T13 in a single tube reaction. The study results reveal that this assay has a sensitivity and specificity superior to the SBT and a cost much lower than the NGS-NIPT. Thus, from both the test performance and the economic benefit points of views, using the dPCR-NIPT assay to replace the SBT as a primary screen tool followed by the NGS-NIPT rescreen would be a better approach than the existing CS for detection of fetal aneuploidies in maternal plasma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-022-03455-y","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T10:02:53Z","timestamp":1655287373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A dPCR-NIPT assay for detections of trisomies 21, 18 and 13 in a single-tube reaction-could it replace serum biochemical tests as a primary maternal plasma screening tool?"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-5832","authenticated-orcid":false,"given":"Peng","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimeng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"issue":"24","key":"3455_CR1","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1056\/NEJMra1706537","volume":"382","author":"MJ Bull","year":"2020","unstructured":"Bull MJ. Down Syndrome. N Engl J Med. 2020;382(24):2344\u201352.","journal-title":"N Engl J Med"},{"key":"3455_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1750-1172-7-81","volume":"7","author":"A Cereda","year":"2012","unstructured":"Cereda A, Carey JC. The trisomy 18 syndrome. Orphanet J Rare Dis. 2012;7:81.","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"3455_CR3","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/ajmg.a.61365","volume":"179","author":"N Goel","year":"2019","unstructured":"Goel N, Morris JK, Tucker D, de Walle HEK, Bakker MK, Kancherla V, Marengo L, Canfield MA, Kallen K, Lelong N, Camelo JL, Stallings EB, Jones AM, Nance A, Huynh MP, Martinez-Fernandez ML, Sipek A, Pierini A, Nembhard WN, Goetz D, Rissmann A, Groisman B, Luna-Munoz L, Szabova E, Lapchenko S, Zarante I, Hurtado-Villa P, Martinez LE, Tagliabue G, Landau D, Gatt M, Dastgiri S, Morgan M. Trisomy 13 and 18-Prevalence and mortality-A multi-registry population based analysis. Am J Med Genet A. 2019;179(12):2382\u201392.","journal-title":"Am J Med Genet A"},{"key":"3455_CR4","doi-asserted-by":"publisher","DOI":"10.18294\/sc.2019.1863","volume":"15","author":"J Martini","year":"2019","unstructured":"Martini J, Bidondo MP, Duarte S, Liascovich R, Barbero P, Groisman B. Birth prevalence of Down syndrome in Argentina. Salud Colect. 2019;15: e1863.","journal-title":"Salud Colect"},{"issue":"18","key":"3455_CR5","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/bdr2.1589","volume":"111","author":"CT Mai","year":"2019","unstructured":"Mai CT, Isenburg JL, Canfield MA, Meyer RE, Correa A, Alverson CJ, Lupo PJ, Riehle-Colarusso T, Cho SJ, Aggarwal D, Kirby RS, National Birth Defects Prevention N. National population-based estimates for major birth defects, 2010\u20132014. Birth Defects Res. 2019;111(18):1420\u201335.","journal-title":"Birth Defects Res"},{"issue":"1","key":"3455_CR6","first-page":"1157","volume":"5","author":"JC Doidge","year":"2020","unstructured":"Doidge JC, Morris JK, Harron KL, Stevens S, Gilbert R. Prevalence of Down\u2019s Syndrome in England, 1998\u20132013: comparison of linked surveillance data and electronic health records. Int J Popul Data Sci. 2020;5(1):1157.","journal-title":"Int J Popul Data Sci"},{"issue":"1","key":"3455_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ddrr.1128","volume":"18","author":"WB Zigman","year":"2013","unstructured":"Zigman WB. Atypical aging in Down syndrome. Dev Disabil Res Rev. 2013;18(1):51\u201367.","journal-title":"Dev Disabil Res Rev"},{"issue":"2","key":"3455_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","volume":"17","author":"AH Bittles","year":"2007","unstructured":"Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health. 2007;17(2):221\u20135.","journal-title":"Eur J Public Health"},{"issue":"1","key":"3455_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH. Down syndrome. Nat Rev Dis Primers. 2020;6(1):9.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3455_CR10","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41598-021-81451-w","volume":"11","author":"I De Toma","year":"2021","unstructured":"De Toma I, Dierssen M. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19. Sci Rep. 2021;11(1):1930.","journal-title":"Sci Rep"},{"issue":"3","key":"3455_CR11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41436-020-01004-w","volume":"23","author":"L Malle","year":"2021","unstructured":"Malle L, Gao C, Hur C, Truong HQ, Bouvier NM, Percha B, Kong XF, Bogunovic D. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease. Genet Med. 2021;23(3):576\u201380.","journal-title":"Genet Med"},{"issue":"12","key":"3455_CR12","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1002\/ajmg.a.61867","volume":"182","author":"ER Villani","year":"2020","unstructured":"Villani ER, Carfi A, Di Paola A, Palmieri L, Donfrancesco C, Lo Noce C, Taruscio D, Meli P, Salerno P, Kodra Y, Pricci F, Tamburo de Bella M, Floridia M, Onder G, Institute IN, of Health Co VIDMG,. Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-a case series. Am J Med Genet A. 2020;182(12):2964\u201370.","journal-title":"Am J Med Genet A"},{"key":"3455_CR13","first-page":"CD011975","volume":"11","author":"SK Alldred","year":"2015","unstructured":"Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP, Alfirevic Z. First trimester serum tests for Down\u2019s syndrome screening. Cochrane Database Syst Rev. 2015;11:CD011975.","journal-title":"Cochrane Database Syst Rev"},{"key":"3455_CR14","doi-asserted-by":"crossref","unstructured":"Steinfort K, Van Houtven E, Jacquemyn Y, Blaumeiser B and Loquet P (2021) Difference in Procedure-Related Risk of Miscarriage between Early and Mid-Trimester Amniocentesis: A Retrospective Cohort Study. Diagnostics (Basel) 11(6):1098.","DOI":"10.3390\/diagnostics11061098"},{"issue":"2","key":"3455_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/uog.10152","volume":"40","author":"K Agarwal","year":"2012","unstructured":"Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies: a systematic review. Ultrasound Obstet Gynecol. 2012;40(2):128\u201334.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"3455_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000271995","volume":"27","author":"A Tabor","year":"2010","unstructured":"Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27(1):1\u20137.","journal-title":"Fetal Diagn Ther"},{"issue":"10","key":"3455_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109173","volume":"9","author":"RM McCullough","year":"2014","unstructured":"McCullough RM, Almasri EA, Guan X, Geis JA, Hicks SC, Mazloom AR, Deciu C, Oeth P, Bombard AT, Paxton B, Dharajiya N, Saldivar JS. Non-invasive prenatal chromosomal aneuploidy testing\u2013clinical experience: 100,000 clinical samples. PLoS ONE. 2014;9(10): e109173.","journal-title":"PLoS ONE"},{"issue":"17","key":"3455_CR18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","volume":"372","author":"ME Norton","year":"2015","unstructured":"Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, Tomlinson MW, Pereira L, Spitz JL, Hollemon D, Cuckle H, Musci TJ, Wapner RJ. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372(17):1589\u201397.","journal-title":"N Engl J Med"},{"issue":"9076","key":"3455_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485\u20137.","journal-title":"Lancet"},{"issue":"51","key":"3455_CR20","doi-asserted-by":"publisher","first-page":"20458","DOI":"10.1073\/pnas.0810641105","volume":"105","author":"RW Chiu","year":"2008","unstructured":"Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, Foo CH, Xie B, Tsui NB, Lun FM, Zee BC, Lau TK, Cantor CR, Lo YM. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A. 2008;105(51):20458\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"3455_CR21","doi-asserted-by":"publisher","first-page":"16266","DOI":"10.1073\/pnas.0808319105","volume":"105","author":"HC Fan","year":"2008","unstructured":"Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008;105(42):16266\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3455_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/clinchem\/48.1.35","volume":"48","author":"LL Poon","year":"2002","unstructured":"Poon LL, Leung TN, Lau TK, Chow KC, Lo YM. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem. 2002;48(1):35\u201341.","journal-title":"Clin Chem"},{"issue":"2","key":"3455_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nm1530","volume":"13","author":"YM Lo","year":"2007","unstructured":"Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, Ding C. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med. 2007;13(2):218\u201323.","journal-title":"Nat Med"},{"issue":"12","key":"3455_CR24","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/pd.4686","volume":"35","author":"R Stokowski","year":"2015","unstructured":"Stokowski R, Wang E, White K, Batey A, Jacobsson B, Brar H, Balanarasimha M, Hollemon D, Sparks A, Nicolaides K, Musci TJ. Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies. Prenat Diagn. 2015;35(12):1243\u20136.","journal-title":"Prenat Diagn"},{"issue":"32","key":"3455_CR25","doi-asserted-by":"publisher","first-page":"13116","DOI":"10.1073\/pnas.0705765104","volume":"104","author":"YM Lo","year":"2007","unstructured":"Lo YM, Lun FM, Chan KC, Tsui NB, Chong KC, Lau TK, Leung TY, Zee BC, Cantor CR, Chiu RW. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A. 2007;104(32):13116\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3455_CR26","first-page":"1","volume":"19","author":"O Health Quality","year":"2019","unstructured":"Health Quality O. Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions: a health technology assessment. Ont Health Technol Assess Ser. 2019;19(4):1\u2013166.","journal-title":"Ont Health Technol Assess Ser"},{"issue":"1","key":"3455_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010002","volume":"6","author":"S Taylor-Phillips","year":"2016","unstructured":"Taylor-Phillips S, Freeman K, Geppert J, Agbebiyi A, Uthman OA, Madan J, Clarke A, Quenby S, Clarke A. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open. 2016;6(1): e010002.","journal-title":"BMJ Open"},{"issue":"1","key":"3455_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/aogs.13047","volume":"96","author":"E Iwarsson","year":"2017","unstructured":"Iwarsson E, Jacobsson B, Dagerhamn J, Davidson T, Bernabe E, Heibert Arnlind M. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population-a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017;96(1):7\u201318.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"3455_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1471-0528.14050","volume":"124","author":"FL Mackie","year":"2017","unstructured":"Mackie FL, Hemming K, Allen S, Morris RK, Kilby MD. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG. 2017;124(1):32\u201346.","journal-title":"BJOG"},{"issue":"11","key":"3455_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/medethics-2020-106218","volume":"46","author":"EM Bunnik","year":"2020","unstructured":"Bunnik EM, Kater-Kuipers A, Galjaard RH, de Beaufort I. Why NIPT should be publicly funded. J Med Ethics. 2020;46(11):783\u20134.","journal-title":"J Med Ethics"},{"issue":"1","key":"3455_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12687-020-00498-w","volume":"12","author":"ME Benoy","year":"2021","unstructured":"Benoy ME, Iruretagoyena JI, Birkeland LE, Petty EM. The impact of insurance on equitable access to non-invasive prenatal screening (NIPT): private insurance may not pay. J Community Genet. 2021;12(1):185\u201397.","journal-title":"J Community Genet"},{"issue":"1","key":"3455_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/uog.14693","volume":"45","author":"MI Evans","year":"2015","unstructured":"Evans MI, Sonek JD, Hallahan TW, Krantz DA. Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies. Ultrasound Obstet Gynecol. 2015;45(1):74\u201383.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3455_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12962-019-0173-8","volume":"17","author":"JC Bayon","year":"2019","unstructured":"Bayon JC, Orruno E, Portillo MI, Asua J. The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis. Cost Eff Resour Alloc. 2019;17:6.","journal-title":"Cost Eff Resour Alloc"},{"issue":"12","key":"3455_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225281","volume":"14","author":"W Zhang","year":"2019","unstructured":"Zhang W, Mohammadi T, Sou J, Anis AH. Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: a microsimulation modeling analysis. PLoS ONE. 2019;14(12): e0225281.","journal-title":"PLoS ONE"},{"issue":"7","key":"3455_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046582","volume":"11","author":"W Shang","year":"2021","unstructured":"Shang W, Wan Y, Chen J, Du Y, Huang J. Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis. BMJ Open. 2021;11(7): e046582.","journal-title":"BMJ Open"},{"issue":"15","key":"3455_CR36","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.clinbiochem.2015.03.015","volume":"48","author":"I Hudecova","year":"2015","unstructured":"Hudecova I. Digital PCR analysis of circulating nucleic acids. Clin Biochem. 2015;48(15):948\u201356.","journal-title":"Clin Biochem"},{"issue":"3","key":"3455_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118833","volume":"10","author":"N Majumdar","year":"2015","unstructured":"Majumdar N, Wessel T, Marks J. Digital PCR modeling for maximal sensitivity, dynamic range and measurement precision. PLoS ONE. 2015;10(3): e0118833.","journal-title":"PLoS ONE"},{"issue":"4","key":"3455_CR38","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/s18041271","volume":"18","author":"PL Quan","year":"2018","unstructured":"Quan PL, Sauzade M, Brouzes E. dPCR: a technology review. Sensors (Basel). 2018;18(4):1271.","journal-title":"Sensors (Basel)"},{"issue":"19","key":"3455_CR39","doi-asserted-by":"publisher","first-page":"7576","DOI":"10.1021\/ac0709394","volume":"79","author":"HC Fan","year":"2007","unstructured":"Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem. 2007;79(19):7576\u20139.","journal-title":"Anal Chem"},{"issue":"7","key":"3455_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/diagnostics11071131","volume":"11","author":"A Nykel","year":"2021","unstructured":"Nykel A, Wozniak R, Gach A. Clinical Validation of Novel Chip-Based Digital PCR Platform for Fetal Aneuploidies Screening. Diagnostics (Basel). 2021;11(7):1131.","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"3455_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155009","volume":"11","author":"LA El Khattabi","year":"2016","unstructured":"El Khattabi LA, Rouillac-Le Sciellour C, Le Tessier D, Luscan A, Coustier A, Porcher R, Bhouri R, Nectoux J, Serazin V, Quibel T, Mandelbrot L, Tsatsaris V, Vialard F, Dupont JM. Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept Study. PLoS ONE. 2016;11(5): e0155009.","journal-title":"PLoS ONE"},{"key":"3455_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cca.2017.11.015","volume":"476","author":"SY Lee","year":"2018","unstructured":"Lee SY, Kim SJ, Han SH, Park JS, Choi HJ, Ahn JJ, Oh MJ, Shim SH, Cha DH, Hwang SY. A new approach of digital PCR system for non-invasive prenatal screening of trisomy 21. Clin Chim Acta. 2018;476:75\u201380.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"3455_CR43","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1039\/C8AN02018C","volume":"144","author":"C Tan","year":"2019","unstructured":"Tan C, Chen X, Wang F, Wang D, Cao Z, Zhu X, Lu C, Yang W, Gao N, Gao H, Guo Y, Zhu L. A multiplex droplet digital PCR assay for non-invasive prenatal testing of fetal aneuploidies. Analyst. 2019;144(7):2239\u201347.","journal-title":"Analyst"},{"key":"3455_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103535","volume":"70","author":"X Chen","year":"2021","unstructured":"Chen X, Li Y, Huang Q, Lin X, Wang X, Wang Y, Liu Y, He Q, Liu Y, Wang T, Ji ZL, Li Q. Segmental duplication as potential biomarkers for non-invasive prenatal testing of aneuploidies. EBioMedicine. 2021;70: 103535.","journal-title":"EBioMedicine"},{"issue":"10","key":"3455_CR45","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1373\/clinchem.2008.111385","volume":"54","author":"FM Lun","year":"2008","unstructured":"Lun FM, Chiu RW, Chan KC, Leung TY, Lau TK, Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem. 2008;54(10):1664\u201372.","journal-title":"Clin Chem"},{"issue":"8","key":"3455_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jogoh.2019.07.001","volume":"48","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, HuoJiaBieKe J, Du S. The influence of fetal gender and maternal characteristics on fetal cell-free DNA in maternal plasma. J Gynecol Obstet Hum Reprod. 2019;48(8):653\u20136.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"1","key":"3455_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40246-019-0244-0","volume":"13","author":"Y Hou","year":"2019","unstructured":"Hou Y, Yang J, Qi Y, Guo F, Peng H, Wang D, Wang Y, Luo X, Li Y, Yin A. Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening. Hum Genomics. 2019;13(1):62.","journal-title":"Hum Genomics"},{"issue":"12","key":"3455_CR48","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/mi11121025","volume":"11","author":"G Xu","year":"2020","unstructured":"Xu G, Si H, Jing F, Sun P, Zhao D, Wu D. A double-deck self-digitization microfluidic chip for digital PCR. Micromachines (Basel). 2020;11(12):1025.","journal-title":"Micromachines (Basel)"},{"issue":"19","key":"3455_CR49","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1039\/D1LC00532D","volume":"21","author":"J Shen","year":"2021","unstructured":"Shen J, Zheng J, Li Z, Liu Y, Jing F, Wan X, Yamaguchi Y, Zhuang S. A rapid nucleic acid concentration measurement system with large field of view for a droplet digital PCR microfluidic chip. Lab Chip. 2021;21(19):3742\u20137.","journal-title":"Lab Chip"},{"issue":"1","key":"3455_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40246-020-00268-2","volume":"14","author":"Y Liu","year":"2020","unstructured":"Liu Y, Liu H, He Y, Xu W, Ma Q, He Y, Lei W, Chen G, He Z, Huang J, Liu J, Liu Y, Huang Q, Yu F. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China. Hum Genomics. 2020;14(1):21.","journal-title":"Hum Genomics"},{"issue":"4","key":"3455_CR51","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000337544","volume":"31","author":"MI Evans","year":"2012","unstructured":"Evans MI, Wright DA, Pergament E, Cuckle HS, Nicolaides KH. Digital PCR for noninvasive detection of aneuploidy: power analysis equations for feasibility. Fetal Diagn Ther. 2012;31(4):244\u20137.","journal-title":"Fetal Diagn Ther"},{"issue":"6","key":"3455_CR52","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/pd.5049","volume":"37","author":"TS Hartwig","year":"2017","unstructured":"Hartwig TS, Ambye L, Sorensen S, Jorgensen FS. Discordant non-invasive prenatal testing (NIPT)\u2014a systematic review. Prenat Diagn. 2017;37(6):527\u201339.","journal-title":"Prenat Diagn"},{"issue":"10","key":"3455_CR53","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/pd.5952","volume":"41","author":"RWK Chiu","year":"2021","unstructured":"Chiu RWK, Lo YMD. Cell-free fetal DNA coming in all sizes and shapes. Prenat Diagn. 2021;41(10):1193\u2013201.","journal-title":"Prenat Diagn"},{"issue":"9","key":"3455_CR54","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315\u20136.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3455_CR55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12884-019-2434-0","volume":"19","author":"MA Sanchez-Duran","year":"2019","unstructured":"Sanchez-Duran MA, Bernabeu Garcia A, Calero I, Ramis Fossas J, Illescas T, Aviles MT, Maiz N, Carreras E. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study. BMC Pregnancy Childbirth. 2019;19(1):274.","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03455-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T12:09:15Z","timestamp":1655294955000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03455-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3455"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03455-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol and informed consent (Ethics number: 2018-YB-08) were approved by the Research and Clinical Trials Ethics Committee of the First Affiliated Hospital of Zhengzhou University. All research participants or their legal representatives signed informed consent forms for participation in clinical and genetic research. All methods were performed in accordance with the relevant guidelines and regulations in accordance with the Declaration of Helsinki in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}